|
|
Reference
|
|
   2
|
Alberti, A., Benvegnu, L. (2003) Management of hepatitis C. J Hepatol, 38 Suppl 1: S104-18
|
|
1
|
Alberti, A., Boccato, S., Vario, A., Benvegnu, L. (2002) Therapy of acute hepatitis C. Hepatology, 36(5 Suppl 1): S195-200
|
|
1
|
Camma, C., Almasio, P., Craxi, A. (1996) Interferon as treatment for acute hepatitis C. A meta-analysis. Dig Dis Sci, 41(6): 1248-55
|
|
|
Delwaide, J., Bourgeois, N., Gerard, C., de Maeght, S., Mokaddem, F., Wain, E., Bastens, B., Fevery, J., Gehenot, M., le Moine, O., Martinet, J.P., Robaeys, G., Servais, B., van Gossum, M., van Vlierberghe, H., Belgian Association for the Study of the Liver (BASL (2004) Treatment of acute hepatitis C with interferon alpha-2b: Early initiation of treatment is the most effective predictive factor of sustained viral response. Aliment Pharmacol Ther, 20(1): 15-22
|
|
|
Fukui, S., Tohyama, H., Iwabuchi, S. (1994) Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects. Nippon Rinsho, 52(7): 1847-51
|
|
|
Gerlach, T., Diepolder, H.M., Zachoval, R., Gruener, N.H., Jung, M., Ulsenheimer, A., Schraut, W.W., Schirren, C., Waechtler, M., Backmund, M., Pape, G.R. (2003) Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology, 125(1): 80-8
|
|
|
Gursoy, M., Gur, G., Arslan, H., Ozdemir, N., Boyacioglu, S. (2001) Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment. J Viral Hepat, 8(1): 70-7
|
|
3
|
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., Manns, M.P. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med, 345(20): 1452-7
|
|
|
Kamal, S.M., Ismail, A., Graham, C.S., He, Q., Rasenack, J.W., Peters, T., Tawil, A.A., Fehr, J.J., Khalifa, K.E.S., Madwar, M.M., Koziel, M.J. (2004) Pegylated interferon alpha therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kinetics. Hepatology, 39(6): 1721-31
|
|
|
Kenny-Walsh, E. (1999) Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med, 340(16): 1228-33
|
|
|
Lehmann, M., Meyer, M.F., Monazahian, M., Tillmann, H.L., Manns, M.P., Wedemeyer, H. (2004) High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol, 73(3): 387-91
|
|
5
|
Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M., Albrecht, J.K. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet, 358(9286): 958-65
|
|
|
Nomura, H., Sou, S., Tanimoto, H., Nagahama, T., Kimura, Y., Hayashi, J., Ishibashi, H., Kashiwagi, S. (2004) Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial. Hepatology, 39(5): 1213-9
|
|
|
Quin, J.W. (1997) Interferon therapy for acute hepatitis C viral infection: A review by meta-analysis. Aust N Z J Med, 27(5): 611-7; dis
|
|
|
Santantonio, T. (2004) Treatment of acute hepatitis C. Curr Pharm Des, 10(17): 2077-80
|
|
|
Santantonio, T., Sinisi, E., Guastadisegni, A., Casalino, C., Mazzola, M., Gentile, A., Leandro, G., Pastore, G. (2003) Natural course of acute hepatitis C: A long-term prospective study. Dig Liver Dis, 35(2): 104-13
|
|
|
Thevenot, T., Regimbeau, C., Ratziu, V., Leroy, V., Opolon, P., Poynard, T. (2001) Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update. J Viral Hepat, 8(1): 48-62
|
|
2
|
Vogel, W. (1999) Treatment of acute hepatitis C virus infection. J Hepatol, 31 Suppl 1: 189-92
|
|
1
|
Wiese, M., Berr, F., Lafrenz, M., Porst, H., Oesen, U. (2000) Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter study. Hepatology, 32(1): 91-6
|
|
|
|
|